Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hilton Baltimore Inner Harbor

Apr 05, 2027 8:00 AM - Apr 07, 2027 12:30 PM

401 W Pratt Street, Baltimore, MD 21201, USA

Global Pharmacovigilance and Risk Management Strategies Conference

Early Bird Rate Ends

DAYS

HOURS

MINUTES

SECONDS

Session 11: From Qualitative to Quantitative, Practical Frameworks for Benefit-Risk Decisions

Session Chair(s)

Michael Von Forstner, PhD, MPH, MSc

Michael Von Forstner, PhD, MPH, MSc

Managing Director, Head of Pharmacoepidemiology Practice, Mesa Laubela Consulting, Switzerland

Balmeet  Gurm, MD

Balmeet Gurm, MD

Executive Director, Therapeutic Area Lead Cardiovascular and EBs, Patient Safety, Bristol Myers Squibb, United States

This session explores the evolution of structured benefit-risk assessment and how organizations are building practical frameworks to support transparent, consistent, science-driven decision making across the product lifecycle. Speakers will show how qualitative, semi-quantitative, and quantitative approaches come together to strengthen regulatory communications, risk management, and benefit-risk evaluations, using a real-world framework developed at BMS as a case study.

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.